RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia

Isabel Jerchel; Alex Hoogkamer; Ingrid Aries; Lieneke Steeghs; Judith Boer; N J M Besselink; Aurélie Boeree; Cesca Ven; HA de Groot-Kruseman; V de Haas; MA Horstmann; G Escherich; C.M. Zwaan; E Cuppen; MJ Koudijs; Rob Pieters; Monique den Boer

doi:10.1038/leu.2017.303

RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia

Isabel Jerchel, Alex Hoogkamer, Ingrid Aries, Lieneke Steeghs, Judith Boer, N J M Besselink, Aurélie Boeree, Cesca Ven, HA de Groot-Kruseman, V de Haas, MA Horstmann, G Escherich, C.M. Zwaan, E Cuppen, MJ Koudijs, Rob Pieters, Monique den Boer

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

62 Citations (Scopus)

3 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	931-940
Number of pages	10
Journal	Leukemia
Volume	32
Issue number	4
DOIs	https://doi.org/10.1038/leu.2017.303
Publication status	Published - 2018

Access to Document

10.1038/leu.2017.303

RePub-111940-OA.pdfFinal published version, 601 KB

http://hdl.handle.net/1765/111940

Cite this

Jerchel, I., Hoogkamer, A., Aries, I., Steeghs, L., Boer, J., Besselink, N. J. M., Boeree, A., Ven, C., de Groot-Kruseman, HA., de Haas, V., Horstmann, MA., Escherich, G., Zwaan, C. M., Cuppen, E., Koudijs, MJ., Pieters, R., & den Boer, M. (2018). RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia. Leukemia, 32(4), 931-940. https://doi.org/10.1038/leu.2017.303

@article{16bdd53f2b294030825433da2bb65889,

title = "RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia",

author = "Isabel Jerchel and Alex Hoogkamer and Ingrid Aries and Lieneke Steeghs and Judith Boer and Besselink, {N J M} and Aur{\'e}lie Boeree and Cesca Ven and {de Groot-Kruseman}, HA and {de Haas}, V and MA Horstmann and G Escherich and C.M. Zwaan and E Cuppen and MJ Koudijs and Rob Pieters and {den Boer}, Monique",

year = "2018",

doi = "10.1038/leu.2017.303",

language = "Undefined/Unknown",

volume = "32",

pages = "931--940",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "4",

}

Jerchel, I, Hoogkamer, A, Aries, I, Steeghs, L, Boer, J, Besselink, NJM, Boeree, A, Ven, C, de Groot-Kruseman, HA, de Haas, V, Horstmann, MA, Escherich, G, Zwaan, CM, Cuppen, E, Koudijs, MJ, Pieters, R & den Boer, M 2018, 'RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia', Leukemia, vol. 32, no. 4, pp. 931-940. https://doi.org/10.1038/leu.2017.303

TY - JOUR

T1 - RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia

AU - Jerchel, Isabel

AU - Hoogkamer, Alex

AU - Aries, Ingrid

AU - Steeghs, Lieneke

AU - Boer, Judith

AU - Besselink, N J M

AU - Boeree, Aurélie

AU - Ven, Cesca

AU - de Groot-Kruseman, HA

AU - de Haas, V

AU - Horstmann, MA

AU - Escherich, G

AU - Zwaan, C.M.

AU - Cuppen, E

AU - Koudijs, MJ

AU - Pieters, Rob

AU - den Boer, Monique

PY - 2018

Y1 - 2018

U2 - 10.1038/leu.2017.303

DO - 10.1038/leu.2017.303

M3 - Article

SN - 0887-6924

VL - 32

SP - 931

EP - 940

JO - Leukemia

JF - Leukemia

IS - 4

ER -